This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Loblaw, D. A. Articles by Laperriere, N. J. Search for Related Content PubMed PubMed Citation Articles by Loblaw, D. A. Articles by Laperriere, N. J. Social Bookmarking                            What's this?

Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative‘s Neuro-Oncology Disease Site Group

From the Departments of Radiation Oncology and Medicine, Sunnybrook and Women's College Health Science Centre, University of Toronto; Department of Radiation Oncology, Princess Margaret Hospital/University Health Network, University of Toronto, Toronto; and Program in Evidence-Based Care, Cancer Care Ontario, McMaster University, Hamilton, Ontario, Canada

Address reprint requests to D. Andrew Loblaw, MD, Rm T2-104, 2075 Bayview Ave, Toronto, Ontario, Canada, M4N 3M5; e-mail: andrew.loblaw{at}sw.ca

PURPOSE: This systematic review describes the diagnosis and management of adult patients with a suspected or confirmed diagnosis of extradural malignant spinal cord compression (MSCC).

METHODS: MEDLINE, CANCERLIT, and the Cochrane Library databases were searched to January 2004 using the following terms: spinal cord compression, nerve compression syndromes, spinal cord neoplasms, clinical trial, meta-analysis, and systematic review.

RESULTS: Symptoms for MSCC include sensory changes, autonomic dysfunction, and back pain; however, back pain was not predictive of MSCC. The sensitivity and specificity for magnetic resonance imaging (MRI) range from 0.44 to 0.93 and 0.90 to 0.98, respectively, in the diagnosis of MSCC. The sensitivity and specificity for myelography range from 0.71 to 0.97 and 0.88 to 1.00, respectively. A randomized study detected higher ambulation rates in patients with MSCC who received high-dose dexamethasone before radiotherapy (RT) compared with patients who did not receive corticosteroids before RT (81% v 63% at 3 months, respectively; P = .046). There is no direct evidence that supports or refutes the type of surgery patients should have for the treatment of MSCC, whether surgical salvage should be attempted if patient is progressing on or shortly after RT, and whether patients with spinal instability should be treated with surgery.

CONCLUSION: Patients with symptoms of MSCC should be managed to minimize treatment delay. MRI is the preferred imaging technique. Treatment for patients with MSCC should consider pretreatment ambulatory status, comorbidities, technical surgical factors, the presence of bony compression and spinal instability, potential surgical complications, potential RT reactions, and patient preferences.

Supported by Cancer Care Ontario and the Ontario Ministry of Health and Long-Term Care.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. H. Furstenberg, B. Wiedenhofer, H. J. Gerner, and C. Putz The effect of early surgical treatment on recovery in patients with metastatic compression of the spinal cord J Bone Joint Surg Br, February 1, 2009; 91-B(2): 240 - 244. [Abstract] [Full Text] [PDF]

				J. L. Abrahm, R. A. Patchell, and D. Rades Personalized Treatment for Malignant Spinal Cord Compression: A Multidisciplinary Approach ASCO Educational Book, January 1, 2009; 2009(1): 555 - 562. [Abstract] [Full Text] [PDF]

				B D White, A J Stirling, E Paterson, K Asquith-Coe, A Melder, and on behalf of the Guideline Development Group Diagnosis and management of patients at risk of or with metastatic spinal cord compression: summary of NICE guidance BMJ, November 27, 2008; 337(nov27_1): a2538 - a2538. [Full Text]

				S. M. Dy, S. M. Asch, A. Naeim, H. Sanati, A. Walling, and K. A. Lorenz Evidence-Based Standards for Cancer Pain Management J. Clin. Oncol., August 10, 2008; 26(23): 3879 - 3885. [Abstract] [Full Text] [PDF]

				R. H. M. A. Bartels, Y. M. van der Linden, and W. T. A. van der Graaf Spinal Extradural Metastasis: Review of Current Treatment Options CA Cancer J Clin, July 1, 2008; 58(4): 245 - 259. [Abstract] [Full Text] [PDF]

				J. L. Abrahm, M. B. Banffy, and M. B. Harris Spinal Cord Compression in Patients With Advanced Metastatic Cancer: "All I Care About Is Walking and Living My Life" JAMA, February 27, 2008; 299(8): 937 - 946. [Abstract] [Full Text] [PDF]

				R. Chou, A. Qaseem, V. Snow, D. Casey, J. T. Cross Jr, P. Shekelle, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society Ann Intern Med, October 2, 2007; 147(7): 478 - 491. [Abstract] [Full Text] [PDF]

				T. R. Halfdanarson, W. J. Hogan, and T. J. Moynihan Oncologic Emergencies: Diagnosis and Treatment Mayo Clin. Proc., June 1, 2006; 81(6): 835 - 848. [Abstract] [Full Text] [PDF]

				M. C. Chamberlain, A. Sloan, and F. Vrionis Systematic Review of the Diagnosis and Management of Malignant Extradural Spine Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group J. Clin. Oncol., October 20, 2005; 23(30): 7750 - 7751. [Full Text] [PDF]

				D. A. Loblaw, N. J. Laperriere, and J. Perry In Reply J. Clin. Oncol., October 20, 2005; 23(30): 7751 - 7752. [Full Text] [PDF]